Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism αvβ1 inhibitors(Integrin alpha-V/beta-1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Pancreatic Ductal Adenocarcinoma | Preclinical | US | 22 Mar 2024 | |
Advanced Pancreatic Ductal Adenocarcinoma | Preclinical | AU | 22 Mar 2024 |